SCHEMBL25782959

SCHEMBL25782959

CCOC(=O)c1ccn(C)c1CCCCOCc1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ PDE3B Q13370 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ MAOB P27338 2/20 0.43
▸ ALOX5 P09917 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ GRM5 P41594 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25782990 0.88 NR4A2 (0.43) MAOBBCHE
SCHEMBL25782950 0.79 PDE3B (0.48) KMT2ASMN1; SMN2PDE3BPDE3AMAOB
SCHEMBL25782746 0.79 PDE3B (0.46) KMT2ASMN1; SMN2PDE3BPDE3AMAOB
SCHEMBL25782854 0.77 S1PR1 (0.40) KMT2AMEN1LMNAMAPTBCHE
SCHEMBL25782852 0.76 TSHR (0.38) KMT2ASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL25782745 0.71 EPHX2 (0.47) MAOBKDM4EALDH1A1MAPTMAPK1
SCHEMBL19555403 0.71 MAOB (0.49) KMT2ASMN1; SMN2PDE3BPDE3AMAOB
SCHEMBL20379000 0.69 MAOB (0.50) MAOBALOX5
SCHEMBL8880826 0.68 CYP3A4 (0.53) KMT2AMAOB
SCHEMBL25782743 0.68 THRA (0.53) KMT2ASMN1; SMN2MAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023115203-A1 OXER1 ANTAGONISTS AND USES THEREOF FAIRHAVEN PHARMACEUTICALS INC. (CA) 2023-06-29 — — WO disclosed
Send feedback